Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155460 | SCV000205151 | benign | not specified | 2013-02-21 | criteria provided, single submitter | clinical testing | Leu561Leu in exon 16 of AP3B1: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 6.8% (587/8600) of European American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs17192146). |
Prevention |
RCV000155460 | SCV000309767 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000280057 | SCV000458300 | likely benign | Hermansky-Pudlak syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001512412 | SCV001719836 | benign | Hermansky-Pudlak syndrome 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001675643 | SCV001894714 | benign | not provided | 2018-11-10 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002260995 | SCV002542768 | benign | Autoinflammatory syndrome | 2016-12-12 | criteria provided, single submitter | clinical testing |